Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Pharmaceutical Sciences » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Theory of Literature
$243.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Duloxetine: Clinical Uses, Mechanism of Action and Efficacy
Tell A Friend
 
Tell someone you know about this product.
Duloxetine: Clinical Uses, Mechanism of Action and Efficacy
Retail Price: $160.00
10% Online Discount
You Pay:

$144.00
Authors: Trevor Norman, Ph.D., and James S. Olver (Department of Psychiatry, University of Melbourne, Austin Hospital, Victoria, Australia) 
Book Description:
The class of serotonin and noradrenaline reuptake inhibitors (or SNRIs) were introduced into clinical use as a result of the perceived short-comings of other antidepressant medications. Considerations of efficacy, side effects and tolerability have consistently indicated that there is a clinical need for agents demonstrating improvements in one or more of these domains. Since its introduction in 2007, duloxetine, a representative of the SNRI class, has been shown to be as effective for the treatment of major depression as agents with a longer history of use. In addition, duloxetine has demonstrated efficacy in a number of other conditions and has been extensively investigated in the treatment of generalised anxiety disorder and neuropathic pain states. The effectiveness of duloxetine in other anxiety states is not as soundly investigated, but the extant evidence is reviewed. Such disorders represent a fertile ground to explore the boundaries of duloxetine therapeutics, with the attended possibility of significant benefits to a broader patient cohort. This volume brings together the clinical evidence for efficacy in these important conditions. Additionally, it explores in detail the pharmacokinetics, metabolism and mechanism of action of the drug. All medications have side effects associated with their use and duloxetine is no exception. A detailed examination of the presentation and incidence of common events associated with the use of the drug as well as rarer treatment emergent adverse events is outlined. Duloxetine presents itself as a first line treatment of major depressive disorder and as a clinically significant treatment for depressive disorders co-morbid with anxiety and pain states. (Nova Medicine and Health)

Table of Contents:
Chapter 1. Rationale for SNRI Antidepressants

Chapter 2. Pharmacology of Duloxetine

Chapter 3. Duloxetine Pharmacokinetics and Metabolism

Chapter 4. Duloxetine Treatment in Major Depression

Chapter 5. Treatment of Anxiety Disorders with Duloxetine

Chapter 6. Treatment of Pain States

Chapter 7. Adverse Events, Safety and Toxicity

   Series:
      Pharmacology - Research, Safety Testing and Regulation
   Binding: Hardcover
   Pub. Date: 2018 - November
   ISBN: 978-1-53614-327-0
   Status: AP
  
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
  
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Duloxetine: Clinical Uses, Mechanism of Action and Efficacy